A new predictive factor for hepatocellular carcinoma based on two-dimensional electrophoresis of genomic DNA

Osamu Itano, Masakazu Ueda, Kiyoshi Kikuchi, Motohide Shimazu, Yuukou Kitagawa, Kouichi Aiura, Masaki Kitajima

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Molecular genetic analyses have clarified that accumulation of genomic changes provides important steps in carcinogenesis and have identified a number of valuable genetic markers for certain cancers. To date, however, no prognostic markers have been identified for hepatocellular carcinoma (HCC). In this study, we used restriction landmark genomic scanning (RLGS), a new high-speed screening method for multiple genomic changes, to detect unknown genetic alterations in HCC. Thirty-one HCC samples and their normal counterparts were examined by RLGS. Eight spot changes were common in several cases, and all were seen only on the HCC profile. Five of these spots were detected in more than 12 of 31 cases (38.7%). Viral infection had no influence on changes in the RLGS spots. The disease-free survival rate for patients with ≥ 16 changed RLGS spots was significantly lower than that for patients with fewer changed RLGS spots( ≤ 15 spots) (P < 0.001). In multivariate analysis, the number of changed spots was proven to retain an independent prognostic value (relative risk 1.095: P = 0.0031). These results suggest that the number of changed RLGS spots may be a useful biological marker for recurrence of HCC.

Original languageEnglish
Pages (from-to)1676-1683
Number of pages8
JournalOncogene
Volume19
Issue number13
Publication statusPublished - 2000 Mar 23

Fingerprint

Electrophoresis
Hepatocellular Carcinoma
DNA
Virus Diseases
Genetic Markers
Disease-Free Survival
Molecular Biology
Carcinogenesis
Multivariate Analysis
Survival Rate
Biomarkers
Recurrence
Neoplasms

Keywords

  • Disease-free survival
  • Genetic marker
  • HCC
  • Postoperative recurrence
  • RLGS

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Itano, O., Ueda, M., Kikuchi, K., Shimazu, M., Kitagawa, Y., Aiura, K., & Kitajima, M. (2000). A new predictive factor for hepatocellular carcinoma based on two-dimensional electrophoresis of genomic DNA. Oncogene, 19(13), 1676-1683.

A new predictive factor for hepatocellular carcinoma based on two-dimensional electrophoresis of genomic DNA. / Itano, Osamu; Ueda, Masakazu; Kikuchi, Kiyoshi; Shimazu, Motohide; Kitagawa, Yuukou; Aiura, Kouichi; Kitajima, Masaki.

In: Oncogene, Vol. 19, No. 13, 23.03.2000, p. 1676-1683.

Research output: Contribution to journalArticle

Itano, O, Ueda, M, Kikuchi, K, Shimazu, M, Kitagawa, Y, Aiura, K & Kitajima, M 2000, 'A new predictive factor for hepatocellular carcinoma based on two-dimensional electrophoresis of genomic DNA', Oncogene, vol. 19, no. 13, pp. 1676-1683.
Itano O, Ueda M, Kikuchi K, Shimazu M, Kitagawa Y, Aiura K et al. A new predictive factor for hepatocellular carcinoma based on two-dimensional electrophoresis of genomic DNA. Oncogene. 2000 Mar 23;19(13):1676-1683.
Itano, Osamu ; Ueda, Masakazu ; Kikuchi, Kiyoshi ; Shimazu, Motohide ; Kitagawa, Yuukou ; Aiura, Kouichi ; Kitajima, Masaki. / A new predictive factor for hepatocellular carcinoma based on two-dimensional electrophoresis of genomic DNA. In: Oncogene. 2000 ; Vol. 19, No. 13. pp. 1676-1683.
@article{68c955693ce84ce9b2ef1457613f90a0,
title = "A new predictive factor for hepatocellular carcinoma based on two-dimensional electrophoresis of genomic DNA",
abstract = "Molecular genetic analyses have clarified that accumulation of genomic changes provides important steps in carcinogenesis and have identified a number of valuable genetic markers for certain cancers. To date, however, no prognostic markers have been identified for hepatocellular carcinoma (HCC). In this study, we used restriction landmark genomic scanning (RLGS), a new high-speed screening method for multiple genomic changes, to detect unknown genetic alterations in HCC. Thirty-one HCC samples and their normal counterparts were examined by RLGS. Eight spot changes were common in several cases, and all were seen only on the HCC profile. Five of these spots were detected in more than 12 of 31 cases (38.7{\%}). Viral infection had no influence on changes in the RLGS spots. The disease-free survival rate for patients with ≥ 16 changed RLGS spots was significantly lower than that for patients with fewer changed RLGS spots( ≤ 15 spots) (P < 0.001). In multivariate analysis, the number of changed spots was proven to retain an independent prognostic value (relative risk 1.095: P = 0.0031). These results suggest that the number of changed RLGS spots may be a useful biological marker for recurrence of HCC.",
keywords = "Disease-free survival, Genetic marker, HCC, Postoperative recurrence, RLGS",
author = "Osamu Itano and Masakazu Ueda and Kiyoshi Kikuchi and Motohide Shimazu and Yuukou Kitagawa and Kouichi Aiura and Masaki Kitajima",
year = "2000",
month = "3",
day = "23",
language = "English",
volume = "19",
pages = "1676--1683",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "13",

}

TY - JOUR

T1 - A new predictive factor for hepatocellular carcinoma based on two-dimensional electrophoresis of genomic DNA

AU - Itano, Osamu

AU - Ueda, Masakazu

AU - Kikuchi, Kiyoshi

AU - Shimazu, Motohide

AU - Kitagawa, Yuukou

AU - Aiura, Kouichi

AU - Kitajima, Masaki

PY - 2000/3/23

Y1 - 2000/3/23

N2 - Molecular genetic analyses have clarified that accumulation of genomic changes provides important steps in carcinogenesis and have identified a number of valuable genetic markers for certain cancers. To date, however, no prognostic markers have been identified for hepatocellular carcinoma (HCC). In this study, we used restriction landmark genomic scanning (RLGS), a new high-speed screening method for multiple genomic changes, to detect unknown genetic alterations in HCC. Thirty-one HCC samples and their normal counterparts were examined by RLGS. Eight spot changes were common in several cases, and all were seen only on the HCC profile. Five of these spots were detected in more than 12 of 31 cases (38.7%). Viral infection had no influence on changes in the RLGS spots. The disease-free survival rate for patients with ≥ 16 changed RLGS spots was significantly lower than that for patients with fewer changed RLGS spots( ≤ 15 spots) (P < 0.001). In multivariate analysis, the number of changed spots was proven to retain an independent prognostic value (relative risk 1.095: P = 0.0031). These results suggest that the number of changed RLGS spots may be a useful biological marker for recurrence of HCC.

AB - Molecular genetic analyses have clarified that accumulation of genomic changes provides important steps in carcinogenesis and have identified a number of valuable genetic markers for certain cancers. To date, however, no prognostic markers have been identified for hepatocellular carcinoma (HCC). In this study, we used restriction landmark genomic scanning (RLGS), a new high-speed screening method for multiple genomic changes, to detect unknown genetic alterations in HCC. Thirty-one HCC samples and their normal counterparts were examined by RLGS. Eight spot changes were common in several cases, and all were seen only on the HCC profile. Five of these spots were detected in more than 12 of 31 cases (38.7%). Viral infection had no influence on changes in the RLGS spots. The disease-free survival rate for patients with ≥ 16 changed RLGS spots was significantly lower than that for patients with fewer changed RLGS spots( ≤ 15 spots) (P < 0.001). In multivariate analysis, the number of changed spots was proven to retain an independent prognostic value (relative risk 1.095: P = 0.0031). These results suggest that the number of changed RLGS spots may be a useful biological marker for recurrence of HCC.

KW - Disease-free survival

KW - Genetic marker

KW - HCC

KW - Postoperative recurrence

KW - RLGS

UR - http://www.scopus.com/inward/record.url?scp=0034704794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034704794&partnerID=8YFLogxK

M3 - Article

C2 - 10763824

AN - SCOPUS:0034704794

VL - 19

SP - 1676

EP - 1683

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 13

ER -